M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia
暂无分享,去创建一个
R. Coleman | J. Tidy | B. Hancock | M. Winter | J. Ireson | Kam Singh | S. Gillett | A. Hills | K. Singh